BACKGROUND AND PURPOSE: Anti-inflammatory qualities are held partially responsible for the reduction of cardiovascular events after statin treatment. We examined the phenotype of carotid atherosclerotic plaques harvested during carotid endarterectomy in relation to the previous use of different statins prescribed in clinical practice. METHODS: Three hundred and seventy-eight patients were included. Atherosclerotic plaques were harvested, immunohistochemically stained and semiquantitively examined for the presence of macrophages (CD68), smooth muscle cells, collagen and fat. Adjacent atherosclerotic plaques were used to study protease activity and interleukin levels. Patients' demographics were recorded and blood samples were stored. RESULTS: Serum cholesterol, low-density lipoprotein, apolipoprotein B, and C-reactive protein levels were lower in patients treated with statins compared with patients without statin treatment. Atheromatous plaques were less prevalent in patients receiving statins compared with patients without statin therapy (29% versus 42%, P=0.04). An increase of CD68 positive cells was observed in patients receiving statins compared with nonstatin treatment (P=0.05). This effect was specifically related to atorvastatin treatment. In patients treated with atorvastatin, the increased amount of CD68 positive cells were not associated with increased protease activity. In contrast, a dose-dependent decrease in protease activity was shown in the atorvastatin group. Interleukin 6 expression was lower in plaques obtained from patients treated with statins (P=0.04). CONCLUSIONS: Statin use may exert pleiotropic effects on plaque phenotype. However, not the presence of macrophages but activation with subsequent protease and cytokine release may be attenuated by statin use.
BACKGROUND AND PURPOSE: Anti-inflammatory qualities are held partially responsible for the reduction of cardiovascular events after statin treatment. We examined the phenotype of carotid atherosclerotic plaques harvested during carotid endarterectomy in relation to the previous use of different statins prescribed in clinical practice. METHODS: Three hundred and seventy-eight patients were included. Atherosclerotic plaques were harvested, immunohistochemically stained and semiquantitively examined for the presence of macrophages (CD68), smooth muscle cells, collagen and fat. Adjacent atherosclerotic plaques were used to study protease activity and interleukin levels. Patients' demographics were recorded and blood samples were stored. RESULTS: Serum cholesterol, low-density lipoprotein, apolipoprotein B, and C-reactive protein levels were lower in patients treated with statins compared with patients without statin treatment. Atheromatous plaques were less prevalent in patients receiving statins compared with patients without statin therapy (29% versus 42%, P=0.04). An increase of CD68 positive cells was observed in patients receiving statins compared with nonstatin treatment (P=0.05). This effect was specifically related to atorvastatin treatment. In patients treated with atorvastatin, the increased amount of CD68 positive cells were not associated with increased protease activity. In contrast, a dose-dependent decrease in protease activity was shown in the atorvastatin group. Interleukin 6 expression was lower in plaques obtained from patients treated with statins (P=0.04). CONCLUSIONS: Statin use may exert pleiotropic effects on plaque phenotype. However, not the presence of macrophages but activation with subsequent protease and cytokine release may be attenuated by statin use.
Authors: Yuan-Yuan Cui; Xiao-Yi Chen; Lu Ma; Ming-Ming Lu; Guo-En Yao; Jia-Fei Yang; Xi-Hai Zhao; Jian-Ming Cai Journal: Nan Fang Yi Ke Da Xue Xue Bao Date: 2016-04-20
Authors: G M Lanza; P M Winter; S D Caruthers; M S Hughes; Grace Hu; A H Schmieder; S A Wickline Journal: Angiogenesis Date: 2010-04-22 Impact factor: 9.596
Authors: Patrick M Winter; Shelton D Caruthers; Huiying Zhang; Todd A Williams; Samuel A Wickline; Gregory M Lanza Journal: JACC Cardiovasc Imaging Date: 2008-09
Authors: Dominic Pj Howard; Guus W van Lammeren; Peter M Rothwell; Jessica N Redgrave; Frans L Moll; Jean-Paul Pm de Vries; Dominique Pv de Kleijn; Hester M den Ruijter; Gert Jan de Borst; Gerard Pasterkamp Journal: Stroke Date: 2014-12-04 Impact factor: 7.914
Authors: Michael Koutouzis; Kosmas I Paraskevas; Loukianos S Rallidis; Calypso Barbatis; Alexandros Nomikos; Vasiliki Tzavara; Maria Tsopanomichalou; Christos Lioupis; Nikolaos Bessias; Vassilios Andikopoulos; Dimitri P Mikhailidis; Zenon S Kyriakides Journal: Open Cardiovasc Med J Date: 2008-11-28